Bizarre Patents
Mountable Printable Placard With Headband
A resilient headband in a shape for being mounted on the head of the user. The headband is equipped with a longitudinal slotted member for holding a placard.
PatentStorm News
Make the Most of Our Site
See this month's Top Inventors and Most Cited Patents.
Stay on top of the latest innovations by subscribing to an RSS feed.
Registered users: Manage your profile.
| Number | Title | Issue Date |
| 8187833 | Chimeric PCSK9 proteins, cells comprising same, and assays using same A chimera protein comprising in the following order: a signal peptide, a proprotein convertase subtilisin/kexin type 9 preproprotein (PCSK9) sequence consisting of amino acid residues at positions 35 to 696 of SEQ ID NO: 38, a transmembrane domain and a cytosolic do... | 05/29/2012 |
| 8137926 | Kit for assaying EphA4 processing by gamma-secretase The present invention provides a kit for assaying the processing of EphA4 by γ-secretase. ... | 03/20/2012 |
| 8129135 | Method for diagnosing cardiovascular diseases Method for diagnosing a cardiovascular disease in an individual comprising the steps of: providing a sample of an individual; determining the amount of cytokeratin-18 (CK-18) or fragments thereof and/or interleukin-1β precursor (IL-1β precursor) in the sample; com... | 03/06/2012 |
| 8124370 | Cationic anti-microbial peptides and methods of use thereof Described herein are methods of detecting a wound infection and for detecting the presence or absence of microorganisms, for example, wound pathogens in a sample, by contacting a sample with a cationic anti-microbial peptide that is degradable by an enzyme produced ... | 02/28/2012 |
| 8124371 | Compositions and methods for destabilizing lysosomes to increase oncogenic or aberrant protein degradation The present invention relates to compositions for destabilizing lysosomes to increase the degradation of oncogenic or aberrant proteins for the prevention or treatment of disease. Methods for identifying agents which destabilize lysosomes are also provided as are ag... | 02/28/2012 |
| 8071328 | Bioluminescent protease assay A sensitive bioluminescent assay to detect proteases including caspases, trypsin and tryptase is provided. ... | 12/06/2011 |
| 8058024 | Devices for the detection of the presence and/or activity of proteases in biological samples The subject invention provides novel devices and methods for the detection of the presence and/or activity of proteases in biological samples. ... | 11/15/2011 |
| 8053209 | FRET protease assays for clostridial toxins The present invention provides clostridial toxin substrates useful in assaying for the protease activity of any clostridial toxin, including botulinum toxins of all serotypes as well as tetanus toxins. A clostridial toxin substrate of the invention contains a donor ... | 11/08/2011 |
| 8053208 | FRET protease assays for clostridial toxins The present invention provides clostridial toxin substrates useful in assaying for the protease activity of any clostridial toxin, including botulinum toxins of all serotypes as well as tetanus toxins. A clostridial toxin substrate of the invention contains a donor ... | 11/08/2011 |
| 8048643 | FRET protease assays for clostridial toxins The present invention provides clostridial toxin substrates useful in assaying for the protease activity of any clostridial toxin, including botulinum toxins of all serotypes as well as tetanus toxins. A clostridial toxin substrate of the invention contains a donor ... | 11/01/2011 |
| 8012708 | Method for determination of allergen in environment and kit for simple quantification of allergen A simple method for measuring allergens is disclosed, by which the amount of environmental allergens can be measured simply without using an anti-allergen antibody. In the method for measuring an environmental biological allergen(s), a solution containing a substrat... | 09/06/2011 |
| 8012709 | Method for determining if a subject having type II diabetes has a kidney disorder The present invention relates to a method for determining if a subject having Type II diabetes has a kidney disorder by measuring the level of matrix metalloproteinase 8 (MMP-8) in the urine of a subject having Type II diabetes and comparing this level to a referenc... | 09/06/2011 |
| 8012710 | Methods of treating and diagnosing Parkinsons disease and related dysautonomic disorders A method for treating a Parkinson's patient with digestive/pancreatic enzymes involves administering an effective amount of digestive/pancreatic enzymes to an individual having the disorder in order to improve a symptom of the disorder. In addition, a method is prov... | 09/06/2011 |
| 8008036 | Method for identifying autistic individuals amenable to digestive enzyme therapy A method for confirming a diagnosis of autism in an individual comprises obtaining a sample of feces from an individual, determining a quantitative level of chymotrypsin present in the sample, and comparing the quantitative level of fecal chymotrypsin in the stool s... | 08/30/2011 |
| 7998697 | Endotoxin analysis The present invention relates to a method for detecting the presence or non-presence of an endotoxin, characterized in that an OmpT protein is brought into contact with a sample suspected of containing an endotoxin and the protease activity of the OmpT protein is as... | 08/16/2011 |
| 7951553 | Method of assaying glycated protein The present invention provides a convenient, efficient method for assaying glycated protein, fructosyl peptide, or fructosyl amino acid which can be performed with reduced effect of fructosyl lysine compounds. The invention also provides a reagent for the assay.... | 05/31/2011 |
| 7943337 | Method for screening a protease There is provided a method for specifically determining a glycated β-chain N-terminal of glycated hemoglobin using enzymes without a separation operation, and a determination reagent kit therefor. A protease that cleaves a glycated amino acid and/or a glycated pept... | 05/17/2011 |
| 7923219 | Ubiquitin E3 ligase The present invention provides a native or reconstituted complex comprising Bmi1 and/or Ring1 and/or Ring2, wherein the complex has ubiquitin E3 ligase activity. Optionally, the complex further comprises HPH2 and/or HPC3. Also disclosed are methods of producing the ... | 04/12/2011 |
| 7910324 | Method of screening for compounds which affect the processing of EphA4 by γ-secretase The present invention provides a method of screening for compounds which affect the processing of EphA4 by γ-secretase, which includes the following steps: (i) contacting a first biological composition containing γ-secretase or a... | 03/22/2011 |
| 7897364 | Method for determining inhibitors of neurotrypsin The invention relates to a method for determining whether a compound is a neurotrypsin inhibitor, characterized in that the compound is incubated together with neurotrypsin, a variant thereof or a fragment comprising the protease domain and with a protein or peptide... | 03/01/2011 |
| 7892778 | Method of screening for gamma-secretase activity The present invention relates to an improved process for determining γ-secretase activity and for detecting γ-secretase, a subunit protein of γ-secretase, or a γ-secretase-like proteinase. In particular, the present invention relates to processes for the identif... | 02/22/2011 |
| 7892779 | Method of determining chymase activity with secretory leukocyte protease inhibitor It is now discovered that human chymase cleaves human SLPI at a specific site and that this cleavage can be used as an indicator of chymase activity. The present invention provides methods of diagnosing a chymase-associated disease or evaluating the efficiency of a ... | 02/22/2011 |
| 7883863 | Apparatuses and methods for determining protease activity The present invention relates to compositions and an apparatuses for determining protease activity. The compositions of the invention contain a reporter protein fused to at least one protease cleavage sequence, and a linker for attaching the protease cleavage sequen... | 02/08/2011 |
| 7871789 | Method for assaying glycated albumin An albumin denaturing agent for digesting an albumin by a protease efficiently is provided. The albumin denaturing agent contains quaternary ammonium having a hydrocarbon group with a carbon number of 12 or more, or a salt of the quaternary ammonium. The albumin in ... | 01/18/2011 |
| 7829303 | Ligand screening method using a crystal of beta secretase The x-ray crystal structure of BACE or BACE-like proteins is useful for solving the structure of other molecules or molecular complexes, and identifying and/or designing potential modifiers of BACE activity. ... | 11/09/2010 |
| 7820404 | Protein cleavage method and use thereof The present invention provides a method for cleaving a glycated protein to obtain an amino acid or a peptide efficiently with a protease. By treating the glycated protein with the protease in the presence of a compound represented by R—X, the amino acid or the pep... | 10/26/2010 |
| 7807401 | Reagent for digestion of hemoglobin The present invention relates to a reagent for digestion of hemoglobin comprising a buffer, pepsin and a 1,3-dialkyl-imidazolium salt. It also discloses to the use of this reagent in a method for digesting hemoglobin, in a method for detecting HbA1c, and to a... | 10/05/2010 |
| 7803572 | Protease detection assay The invention provides methods and compounds for detecting protease activity in a sample solution comprising contacting the sample solution with a protease substrate labelled with an electrochemically active marker, providing conditions under which any protease whic... | 09/28/2010 |
| 7781183 | Inhibition of anthrax lethal factor protease Disclosed herein is a pharmacophore model for inhibiting anthrax lethal factor protease activity which comprises a first aromatic center A, a second aromatic center B, a first polar center C, a second polar center D, a third polar center E, and a neutral linker F. A... | 08/24/2010 |
| 7749725 | Drug screening and diagnosis based on paracrine tubular renin-angiotensin system The present invention relates to a method for screening drugs for use in treating hypertension using the tubular renin-angiotensinogen system identified by the present invention. The invention further relates to a method to diagnose sodium status and sensitivity in ... | 07/06/2010 |
| 7745166 | Human lysosomal protein and methods of its use The gene associated and causative of classical late infantile neuronal ceroid lipofuscinosis (LINCL), CLN2, has been identified and characterized. The translation product of this gene is a novel protease and a deficiency in this activity results in LINCL. Identifica... | 06/29/2010 |
| 7727739 | Methods for measuring enzyme activity The invention relates to fluorescence methods for measuring enzyme activity, in particular enzyme cleaving and joining activities. The invention also relates to fluorogenic substrates which are useful for measuring enzyme activity and as in vitro and in vivo imaging... | 06/01/2010 |
| 7718391 | Assays for identifying modulators of rhomboid polypeptides The present invention relates to proteins of the conserved Rhomboid family, which are involved in various signalling pathways within cells. Rhomboid proteins are found to possess a novel serine protease activity which cleaves within the transmembrane domain of a pol... | 05/18/2010 |
| 7691597 | Method for measuring protease activity of transglutaminase and transglutaminase composition The invention provides a method for measuring the protease activity of a transglutaminase-containing product comprising: mixing an aqueous solution (sample solution) of a transglutaminase-containing product and an aqueous solution of dimethylcasein in a prescribed r... | 04/06/2010 |
| 7674601 | Fluorescence polarization assays for determining clostridial toxin activity The present invention provides a method of determining the presence or activity of a clostridial toxin by (a) treating with a sample, under conditions suitable for clostridial toxin protease activity, a clostridial toxin substrate which includes a fluorophore; a bul... | 03/09/2010 |
| 7670796 | Metalloprotease assay An assay to detect a metalloprotease in a sample, comprising contacting the sample with a substrate. The metalloprotease reacts with the substrate to form a product comprising a tag. This is followed by selectively binding the tag to a solid phase, wherein the solid... | 03/02/2010 |
| 7662582 | Method of identifying cancer biomarkers and cancer progression An efficient method for identifying important cancer biomarkers and identifying progression of bladder cancer using pro-u-PA as a clinical tool is provided. Searching for biomarkers critical for bladder carcinoma diagnosis and prognosis, secreted proteomes of highly... | 02/16/2010 |
| 7655433 | Methods for high-throughput and quantitative proteome analysis The invention provides methods for identifying and quantifying polypeptides in a sample. The methods include the steps of labeling peptides in a polypeptide sample with an isotope tag; adding a plurality of peptide standards to the polypeptide sample, wherein the pe... | 02/02/2010 |
| 7638294 | Fluorescence polarization assays for determining clostridial toxin activity The present invention provides a method of determining the presence or activity of a clostridial toxin by (a) treating with a sample, under conditions suitable for clostridial toxin protease activity, a clostridial toxin substrate which includes a fluorophore; a bul... | 12/29/2009 |
| 7635573 | Mass spectroscopic method for comparing protein levels in two or more samples The present invention provides a new and improved method for quantitative determination and/or identification of proteins in a sample. In one aspect, the invention provides a mass spectroscopic method for comparing protein levels in two or more samples by differenti... | 12/22/2009 |
